A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S, JET-GBS Group
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
JMIR Res Protoc 2016;5(4):e210
doi: 10.2196/resprot.6610 PMID: 27821382 PMCID: 5118582

Export Metadata

END for: Endnote

BibTeX for: BibDesk, LaTeX

RIS for: RefMan, Procite, Endnote, RefWorks

Add this article to your Mendeley library

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (463)

Download

Download PDF Download XML

Share on Bluesky Share on Twitter Share on Facebook Share on LinkedIn